Search Results

You are looking at 1 - 3 of 3 items for :

  • Laboratory Medicine x
Clear All
Open access

Li-fei Sun, Qiang-qiang Wu, Zhi-hong Sun, Bing Han, Hong-feng Hao, Gui-chen Wang, Ming Li and Jin-biao Zhang

References 1 Szalay B, Acs L, Vásárhelyi B, Kovács L, Balog A. Successful use of tocilizumab in a patient with rheumatoid arthritis following severe pancytopenia during etanercept therapy. J Clin Rheumatol 2011;17(7):377-379. 2 Padigel UM, Lee JJ, Nolan TJ, Schad GA, Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006;74:3232-3238. 3 Letimier FA, Passini N, Gasparian S, Bianchi E, Rogge L. Chromatin

Open access

Wei Dai, Rong Zhou, Hong Yu and Xiao-juan Li

Christman JM, Gerber M, Price PM, Flordellis C, Edelman J, Acs G. Amplication of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci USA 1982;79,1815-1819. 11 Kuo M, Chao M, Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Vriol 1989;63,1945-1950. 12 Taylor J. Hepatitis Delta Virus. Intervirology 1999;42:173-178. 1111 Pan WH, Devlin HF, Kelley C, Isom HC and Clawson GA. A selection

Open access

Zhe An

. Galle-Treger L. Moreau M. Saint-Charles F. Costa S. Ballaire R. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice J. Immunol. 2014 193 817 826 10.4049/jimmunol.1303164 [17] Colpitts C.C., Verrier E.R., Baumert T.F., Targeting viral entry for treatment of hepatitis B and C virus infections, ACS Infect. Dis., 2015, 1, 420-427, 10.1021/acsinfecdis.5b00039 Colpitts C.C. Verrier E.R. Baumert T.F. Targeting viral entry for treatment of hepatitis B and C virus infections ACS Infect